Sears Capital Management
VC
INVESTOR TYPE
Active
STATUS
1
PROFESSIONALS
47
INVESTMENTS
6
PORTFOLIO
39
EXITS
Description
Sears Capital Management is a venture investment firm that specializes in the life sciences. The firm was founded in 1994 and is based in Cupertino, California.
Website
Investor Status
Actively Seeking New Investments
Year Founded
1994
Primary Investor Type
Venture Capital
Primary Office
- 20370 Town Center Lane
- Suite 120
- Cupertino, CA
- United States
+1 (408) 000-0000
Sears Capital Management Investments (47)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Geom Therapeutics | 08-Apr-2017 | Early Stage VC | 00.000 | Biotechnology | Clinical Trials - Phase 1 | 000000 00000 |
| 0000000 0000000000 | 06-Jan-2017 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 000000 00000 |
| 000000 | 01-Mar-2016 | 00000 00000 | 0000 | Therapeutic Devices | Generating Revenue | |
| 0000000 0000000000 | 16-Jul-2015 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue | 000000 00000 |
| 0000000 0000000000 | 23-Sep-2014 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue | 000000 00000 |
| 0000000 0000000 | 30-Apr-2014 | 00000 00000 | Other Healthcare Services | Startup | 000000 00000 | |
| 00000 000000000 | 05-Mar-2014 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| 0000000000 | 19-Feb-2014 | 0000 00000 | 00.00 | Application Software | Bankruptcy: Liquidation | |
| CharlestonPharma | 07-Dec-2012 | Early Stage VC | Diagnostic Equipment | Generating Revenue | 000000 00000 | |
| Cellerant Therapeutics | 21-Sep-2012 | Later Stage VC | 00.000 | Biotechnology | Profitable | 000000 00000 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Sears Capital Management’s full profile, request a free trial.
Sears Capital Management Exits (39)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| TherOx | 18-Jun-2019 | Merger/Acquisition | Completed | ||
| 00000000 000000000 | 31-Jan-2017 | 000000000000000000 | 0000 | Completed |
|
| 0000000000 | 18-May-2016 | 0000000000: 000000 | Completed |
|
|
| 00000 000000000 | 17-Apr-2014 | 000 | 0000 | Completed |
|
| 0000000 0000000000 | 31-Mar-2014 | 000000000000000000 | Completed |
|
|
| 00000000 | 12-Feb-2014 | 000000000000000000 | 000 | Completed |
|
| 000000 0000000000 | 04-Nov-2013 | 0000000000: 000000 | Completed |
|
|
| 000000000 00000000 | 25-Apr-2012 | 000000 0000000000 | 000.00 | Completed |
|
| Chemocentryx | 08-Feb-2012 | IPO | 0000 | Completed |
|
| SteriFix | 16-Nov-2011 | Merger/Acquisition | Completed |
|
Sears Capital Management Team (1)
| Name | Title | Deals | Funds | Boards | Office | Contact Info |
|---|---|---|---|---|---|---|
| Lowell Sears | Chairman, Chief Executive Officer and and Chief Investment Officer | 00 | 0 | Cupertino, CA |
Sears Capital Management Co-Investors (13)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Amgen | 1 | 0 | |
| DAG Ventures | 0 | 0 | 0 |
| Duff Ackerman & Goodrich | 0 | 0 | |
| New Science Ventures | 0 | 0 | |
| ZOLL Medical | 0 | 0 | 0 |